In a filing, Inhibrx Biosciences Inc revealed its Director Kayyem Jon Faiz acquired Company’s shares for reported $0.99 million on Nov 19 ’24. In the deal valued at $14.23 per share,69,686 shares were bought. As a result of this transaction, Kayyem Jon Faiz now holds 51,093 shares worth roughly $0.74 million.
Then, Kayyem Jon Faiz bought 37,500 shares, generating $532,204 in total proceeds. Upon buying the shares at $14.19, the Director now owns 69,843 shares.
Before that, Lappe Mark bought 26,963 shares. Inhibrx Biosciences Inc shares valued at $405,793 were divested by the Chief Executive Officer at a price of $15.05 per share. As a result of the transaction, Lappe Mark now holds 692,511 shares, worth roughly $10.03 million.
JMP Securities initiated its Inhibrx Biosciences Inc [INBX] rating to a Mkt perform in a research note published recently.
Price Performance Review of INBX
On Tuesday, Inhibrx Biosciences Inc [NASDAQ:INBX] saw its stock jump 0.14% to $14.49. Over the last five days, the stock has lost -0.41%. Inhibrx Biosciences Inc shares have risen nearly 4.09% since the year began.
Levels Of Support And Resistance For INBX Stock
The 24-hour chart illustrates a support level at 14.06, which if violated will result in even more drops to 13.63. On the upside, there is a resistance level at 14.80. A further resistance level may holdings at 15.11. The Relative Strength Index (RSI) on the 14-day chart is 45.80, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.64%. Stochastics %K at 40.56% indicates the stock is a holding.
How much short interest is there in Inhibrx Biosciences Inc?
A steep rise in short interest was recorded in Inhibrx Biosciences Inc stocks on 2024-10-31, growing by 0.15 million shares to a total of 0.9 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.74 million shares. There was a rise of 17.1%, which implies that there is a positive sentiment for the stock.
